Top search result for "Kanjinti" in Treatments. To see all results and access other features, sign up for free.

Kanjinti (Trastuzumab-Anns)

Overview
Kanjinti is approved by the U.S. Food and Drug Administration (FDA) for the treatment of HER2-overexpressing breast cancer. This medication is indicated for people with tumors that produce high levels of the HER2…

MyBCTeam is the social network for women facing breast cancer. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for breast cancer. MyBCTeam is the only social network where you can truly connect, make real friendships, and share daily ups and downs in a judgement-free place.

MyBCTeam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment. No information on MyBCTeam should be construed as medical and/or health advice.

Your Privacy is Our Priority

Connect with others who understand.

Top search result for "Kanjinti" in Treatments. To see all results and access other features, sign up for free.

Kanjinti (Trastuzumab-Anns)